Monthly Multi-Institutional Hematopathology Interesting Case Conference
The Multi-Institutional Hematopathology Interesting Case Conference (MHICC) is a monthly virtual CME meeting to provide a platform for oncologists, pathologists, and trainees from leading institutions across North America to collaboratively discuss complex and educational hematopathology cases. This interactive and case-based discussion forum offers a unique opportunity to engage with experts, review complex cases, and strengthen interdisciplinary collaboration in hematopathology.
Schedule for 2025 MHICC
| Date | Presenting Institution |
|---|---|
| February 26 | FCCC |
| March 19 | Mount Sinai |
| May 28 | Cleveland Clinic |
| June 25 | Weill Cornell Medical College |
| August 27 | University of Toronto |
| September 24 | UPenn |
| October 22 | NYU |
| November 26 | Mass General Brigham |
| December 7 | Emory University |
Participating Institutions: Cleveland Clinic, Emory University, Fox Chase Cancer Center, Icahn School of Medicine at Mount Sinai, Mass General Brigham, Memorial Sloan Kettering Cancer Center, National Institutes of Health (NIH), NYU Grossman School of Medicine, University of Pennsylvania, University of Toronto, Weill Cornell Medicine
Upcoming Session
Date: Wednesday, August 27, 2025
Time: 5:00PM (EST)
Presenting Institution: University of Toronto
To Access the Meeting:
1. Click here
2. Sign-in with your EMAIL and click “Next”
3. Enter your personal information requested and click “Sign in Now”
4 .Click “Watch this Lecture Remotely” to enter the meeting
Cases to be Discussed:
Case 1: A 49-year-old man with back pain and a lytic bone lesion in L1 vertebra.– Stains: 1- H&E, 2- CD20, 3- CD138. View Slides
Case 2: 73-year-old man with left inguinal lymphadenopathy,– Stains: 1 – H&E, 2- CD2, 3- CD20. View Slides
Case 3: 66-year-old man with right axillary lymph node enlargement – Stains: 1- H&E, 2- CD20, 3- CD3. View Slides
Case 4: 44-year-old man with cervical lymphadenopathy and history of treated DLBCL,– Stains: 1- H&E, 2- Lysozyme. View Slides
Educational Objectives:
By participating in this monthly conference, attendees will be able to:
- Discuss key concepts related to hematopathology including flow cytometry, broadly-defined molecular, cytogenetic and clinical findings as well as therapeutic implications.
- Identify and analyze challenging hematologic neoplasms, applying updated diagnostic criteria and emerging recommendations to improve patient outcome.
- Integrate novel diagnostic modalities and recent advancements in hematopathology to enhance diagnostic accuracy and facilitate more precise clinical decision-making.
Target Audience:
The MHICC is designed for a diverse audience of healthcare professionals with an interest in hematopathology and related fields. This includes, but is not limited to:
- Pathologists, as well as Medical and Radiation Oncologists
- Fellows, Residents, and Trainees in Pathology, Hematopathology, Molecular Pathology, Hematologic Oncology, and Radiation Oncology
For more information, please contact Reza Nejati, MD, Chair of the Organizing Committee, at Reza.Nejati@fccc.edu.
CME Information and Credit Instructions
To Access your CME Certificate:
After the meeting, you’ll receive an email prompting you to complete a brief evaluation. Once submitted, your credit certificate will be available for download—please remember to save it for your records.
Accreditation Statement:
Temple Health is accredited by the Pennsylvania Medical Society to provide continuing medical education for physicians.
Credit Designation:
Temple Health designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the educational activity.
If you have any questions regarding CME credits, please don’t hesitate to reach out to Lucía Tono at Lucia.Tono-Ramirez@tuhs.temple.edu.
Previous Cases
Date: Wednesday, June 25, 2025
Presenting Institution: Weill Cornell Medical College
Case 1: A 3-year-old boy presenting with stridor and found to have a 0.5 cm mass in the subglottis. View Slides
Case 2: A 68-year-old female with a history of CLL/SLL who presents with worsening abdominal pain. PET-CT showed new FDG avid lymph nodes and multiple hepatic and splenic lesions. View Slides
Case 3: A 61-year-old man with a history of bipolar disorder and alcohol abuse presents with declining mental status over the past month. MRI showed multiple intracerebral lesions. View Slides
Date: Wednesday, May 28, 2025
Presenting Institution: Cleveland Clinic
Case 1: A 74-year-old male with history of squamous cell carcinoma of the tongue now presents with new tonsillar mass.
Case 2: A 65-year-old female with history of Inflammatory bowel disease on treatment presents with incidental finding of left adrenal cyst (16 cm) noted on imaging.
Case 3: An 82-year-old male with history of B-cell lymphoma from an outside hospital, now presenting with visible right neck lymphadenopathy and weight loss. Abbreviated ancillary studies provided for discussion around molecular findings.
Case 4: A 45-year-old male with an isolated enlarged left groin lymph node. View Slides
Date: Wednesday, April 23, 2025
Presenting Institution: MSKCC
Case 1: A 66F w/ history of breast carcinoma status post adjuvant chemotherapy and radiotherapy, presenting with neutropenia (ANC 0.7 K/uL), mild anemia (Hb 10.9 g/dL, MCV 95 fL, RDW 14%), and mild thrombocytopenia (Platelets 126 K/uL). View Slides
Case 2: A 58F w/ a history of a myeloid neoplasm favored to be oligomonocytic chronic myelomonocytic leukemia presents with widespread lymphadenopathy. View Slides
Case 3: A 63F with a history of breast carcinoma status post cytotoxic therapy presents with widespread lytic bone lesions, marked anemia (Hb 6.9 g/dL, MCV 98fL, RDW 22.1%) and thrombocytopenia (Platelets 64 K/uL). View Slides
Date: February 26, 2025
Presenting Institution: FCCC
Case 1: A 70-year-old man with a history of chronic lymphocytic leukemia (CLL) with unexplained neutrophilia. View Slides
Case 2: A 68-year-old man with violaceous-pink raised skin lesions. View Slides
Case 3: A 65-year-old man with a history of multiple myeloma with worsening leukocytosis. View Slides
Case 4: A 56-year-old woman with a history of AML with inversion 16 now with pancytopenia including severe neutropenia at ~220 days post-transplant. View Slides
Date: Wednesday, March 19, 2025
Presenting Institution: Mount Sinai
Case 1: A 70-year-old man with a history of chronic lymphocytic leukemia (CLL) with
unexplained neutrophilia. View Slides
Case 2: A 68-year-old man with violaceous-pink raised skin lesions. View Slides
Case 3: A 65-year-old man with a history of multiple myeloma with worsening leukocytosis. View Slides
Case 4: A 56-year-old woman with a history of AML with inversion 16 now with pancytopenia including severe neutropenia at ~220 days post-transplant. View Slides